Verastem (VSTM) Change in Inventory (2018 - 2026)

Verastem (VSTM) posted quarterly Change in Inventory of $454000.0 for Q1 2026, up 1064.1% quarter-over-quarter from $39000.0 in Q4 2025.

Analysis

Verastem (VSTM) Change in Inventory (2018 - 2026) Analysis & Trends

Verastem's Change in Inventory history runs 5 years deep, the most recent figure standing at $454000.0 for Q1 2026.

In Q1 2026, Change in Inventory changed N/A year-over-year to $454000.0; the TTM figure through Mar 2026 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, changed N/A from the prior year.
Change in Inventory for Q1 2026 stood at $454000.0, up from $39000.0 in the prior quarter.
The five-year high for Change in Inventory was $626000.0 in Q3 2025, with the low at $39000.0 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Vertex Pharmaceuticals	138.51 Bn	130.66 Bn	2.84 Bn	27.70 Mn
2	Regeneron Pharmaceuticals	85.24 Bn	77.25 Bn	3.93 Bn	28.20 Mn
3	Argenx Se	63.46 Bn	58.28 Bn	1.37 Bn	-
4	Moderna	57.89 Bn	52.75 Bn	52.00 Mn	132.00 Mn
5	Revolution Medicines	44.02 Bn	44.02 Bn	-	-
6	BeOne Medicines	39.95 Bn	34.85 Bn	1.53 Bn	47.15 Mn
7	Alnylam Pharmaceuticals	35.49 Bn	32.19 Bn	992.69 Mn	-280,000.00
8	Royalty Pharma	28.43 Bn	27.59 Bn	-	-
9	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	12.97 Mn
10	Verastem	815.95 Mn	679.59 Mn	36.32 Mn	109,000.00

Historic Data

Download Data